Familial aggregation of dementia with Lewy bodies

Archives of Neurology

Volumn 68, Issue 1, 2011, Pages 90-93

  Nervi, Angela ^a   Reitz, Christiane ^a   Tang, Ming Xin ^a,b,c   Santana, Vincent ^a,b   Piriz, Angel ^b   Reyes, Dolly ^b   Lantigua, Rafael ^b   Medrano, Martin ^d   Jiménez Velázquez, Ivonne Z ^e   Lee, Joseph H ^a,b,c   Mayeux, Richard ^a,b,c  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Universidad Tecnológica de Santiago ^*  (United States)

^c University of Puerto Rico School of Medicine ^*  (United States)

^d UNIVERSIDAD TECNOLÓGICA DE SANTIAGO   (Dominican Republic)

^e UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; FEMALE; GENETIC ANALYSIS; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CARIBBEAN REGION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HISPANIC AMERICANS; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 78651306090     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.319     Document Type: Article

References (20)

1. Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002;16(4):203-212.
2. Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part IX: a prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology. 1995;45(11):1991-1995.
3. Lim A, Tsuang D, Kukull W, et al. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc. 1999;47(5):564-569.
4. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47(5):1113-1124.
5. Papapetropoulos S, Lieberman A, Gonzalez J, Singer C, Laufer DZ, Mash DC. Family history of dementia: dementia with Lewy bodies and dementia in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2006;18(1):113-116.
6. Woodruff BK, Graff-Radford NR, Ferman TJ, et al. Family history of dementia is a risk factor for Lewy body disease. Neurology. 2006;66(12):1949- 1950.
7. Sweet RA, Nimgaonkar VL, Devlin B, Lopez OL, DeKosky ST. Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology. 2002;58(6):907-911.
8. Hollingworth P, Hamshere ML, Holmans PA, et al. Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(7):841-848.
9. Romas SN, Santana V, Williamson J, et al. Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE. Arch Neurol. 2002;59(1):87-91.
10. Tang MX, Cross P, Andrews H, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001;56(1):49-56.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
12. McKeith IG, Dickson DW, Lowe J, et al; Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863-1872.
13. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
14. Walker MP, Ayre GA, Cummings JL, et al. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale: two methods to assess fluctuating confusion in dementia. Br J Psychiatry. 2000;177:252-256.
15. Richards M, Marder K, Cote L, Mayeux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord. 1994;9(1):89-91.
16. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol. 1992;49(5):453-460.
17. Stricks L, Pittman J, Jacobs DM, Sano M, Stern Y. Normative data for a brief neuropsychological battery administered to English- and Spanish-speaking community- dwelling elders. J Int Neuropsychol Soc. 1998;4(4):311-318.
18. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545-548.
19. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol. 1995;37(2):254-259.
20. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44(4):1049-1060.